Local Therapy
Sponsors
Shukuya Takehito, M.D. Anderson Cancer Center, Trans Tasman Radiation Oncology Group, Shanghai Children's Medical Center, Mayo Clinic
Conditions
Breast CancerBreast NeoplasmsHepatic Artery Infusion ChemotherapyHepatocellular CarcinomaImmunotherapyLangerhans Cell HistiocytosisLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
Active, not recruitingNCT00929214
Start: 2009-06-24End: 2027-12-01Updated: 2026-06-12
Phase II Study of Local Therapy Combined with Immune Checkpoint Inhibitor for Oligo-Progressive disease
during First-line Immunotherapy in non-small cell lung cancer
RecruitingJPRN-jRCTs031220630
Start: 2023-07-18Target: 32Updated: 2026-06-29
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
RecruitingNCT07062055
Start: 2025-07-25End: 2029-07-25Target: 54Updated: 2026-05-08